Results 271 to 280 of about 274,076 (393)

Understanding clozapine-related blood dyscrasias. Developments, genetics, ethnicity and disparity: it's a CIN. [PDF]

BJPsych Bull
Silva E, Legge S, Casetta C, Whiskey E, Oloyede E, Gee S.   +5 more
europepmc   +1 more source

Correction of neutropenia by portacaval shunt in type IB glycogen storage disease

, 1982
L Corbeel, Mc. Everaerts, Greet Van den Berghe   +2 more
openalex   +1 more source

Long‐term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium

British Journal of Haematology, EarlyView.
The overall survival of patients receiving an allogeneic haematopoietic stem cell transplant (HSCT) for GATA2 deficiency was significantly better if they were transplanted recently, with a bone marrow or cord blood graft and if the transplant was performed before the onset of excess blast. Excess blast before HSCT was the only factor associated with an
Flore Sicre de Fontbrune, Florian Chevillon, Mony Fahd, Kristell Desseaux, Xavier Poiré, Edouard Forcade, Arthur Sterin, Bénédicte Neven, Virginie Gandemer, Sylvain Thepot, Alice Garnier, Bruno Lioure, Ambroise Marcais, Stephanie Nguyen‐Quoc, Suzanne Tavitian, Laure Vincent, Jean Donadieu, Matthieu Resche Riggon, Sylvie Chevret, Marlene Pasquet, Regis Peffault de Latour   +20 more
wiley   +1 more source

Cutaneous T-cell lymphomas may require an exception to the ABHH consensus regarding empiric vancomycin use in febrile neutropenia. [PDF]

Hematol Transfus Cell Ther
Gonzaga Y, Sanches JA.
europepmc   +1 more source

Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non‐Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

British Journal of Haematology, EarlyView.
Summary Developing new therapeutic regimens for relapsed/refractory (R/R) B non‐Hodgkin lymphoma (NHL) patients remains a significant unmet clinical need. Our objective was to evaluate atezolizumab (ATE), obinutuzumab (OBI) and venetoclax (VEN) combination in patients with R/R NHL who had received at least one prior anti‐CD20‐containing ...
Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah, Stéphanie Guidez, Olivier Casasnovas, Pierre Feugier, Gandhi Damaj, Hervé Tilly, Loïc Ysebaert, Steven Le Gouill, Nadine Morineau, Emmanuel Gyan, Rémy Gressin, Roch Houot, Morgane Cheminant, Franck Morschhauser, Catherine Thieblemont, Corinne Haioun, Emmanuelle Nicolas‐Virelizier, Luc‐Matthieu Fornecker, Nicolas Daguindau, Guillaume Cartron   +21 more
wiley   +1 more source

Chemotherapy-induced febrile neutropenia followed by acute hepatitis E virus infection in rectal cancer patient with synchronous liver and lung metastasis: a case report. [PDF]

BMC Infect Dis
Zhang D, Chen Z, Wu J, Ning N, Chen L, Tian X.   +5 more
europepmc   +1 more source

The diversity of mutations and clinical outcomes for ELANE-associated neutropenia

Current opinion in hematology, 2015
Vahagn Makaryan, C. Zeidler, A. Bolyard, J. Skokowa, Elin Rodger, Merideth L. Kelley, L. Boxer, M. Bonilla, P. Newburger, A. Shimamura, B. Zhu, P. Rosenberg, D. Link, K. Welte, D. Dale   +14 more
semanticscholar   +1 more source

The role of blinatumomab in adult acute B lymphoblastic leukaemia

British Journal of Haematology, EarlyView.
Blinatumomab, a CD19‐directed bispecific T‐cell engager, has become a crucial part of BCP‐ALL therapy in r/r disease, MRD‐positive disease and has recently been implemented into first‐line therapy of BCP‐ALL. This review discusses important clinical trials with a focus on blinatumomab in first‐line therapy of adult BCP‐ALL.
Anne C. Wilke, Nicola Gökbuget
wiley   +1 more source

Vancomycin-Induced Severe Neutropenia in a Patient With Osteomyelitis: A Case Report. [PDF]

Cureus
Majeed I, Khan ZR, Harting J, Armes L, Arnold FW.   +4 more
europepmc   +1 more source

A case of systemic lupus erythematosus with severe neutropenia and the effect of high dose globulin therapy.

, 1989
Noriko Nagano, Fuminori Masugi, Mitsuaki Nakamaru, Shigeto Morimoto, T. Shiraishi, Toshio Onishi, Toshio Ogihara, Y Kumahara, Yoshiyuki Kurata   +8 more
openalex   +2 more sources